Epigenetic DNA Methylation and Protein Homocysteinylation: Key Players in Hypertensive Renovascular Damage

Area of Science:

• Nephrology
• Cardiovascular Research
• Epigenetics

Background:

• Hypertension is a major health threat linked to kidney damage, but its mechanisms are not fully understood.
• Hypertensive renal damage involves nephron dysfunction and glomerular changes, leading to reduced kidney function.
• Genetic factors alone do not fully explain hypertension and its associated organ damage.

Purpose of the Study:

• To review the role of epigenetic mechanisms in hypertension and renovascular damage.
• To explore how epigenetic modifications contribute to the pathogenesis of kidney disease.
• To identify potential therapeutic targets for treating hypertension-related renal dysfunction.

Main Methods:

• Literature review of epigenetic hallmarks associated with hypertension.
• Analysis of the role of DNA methylation, histone modifications, noncoding RNAs, and protein N-homocysteinylation.
• Examination of the interplay between biologically active gases (NO, CO, H2S) and epigenetic regulation in the renovascular system.

Main Results:

• Epigenetic modifications like DNA methylation, histone acetylation/deacetylation, noncoding RNAs, and N-homocysteinylation are implicated in hypertension.
• Biologically active gases (NO, CO, H2S) play a role in vascular remodeling and homeostasis, interacting with epigenetic pathways.
• Epigenetic modifications, particularly N-homocysteinylation, directly contribute to hypertensive kidney damage.

Conclusions:

• Epigenetic modulation offers a potential therapeutic avenue for intervening in renovascular damage caused by hypertension.
• Targeting epigenetic mechanisms could lead to novel treatments for renal disease and dysfunction in hypertensive patients.
• Understanding these epigenetic pathways is crucial for developing effective strategies against hypertension and its renal complications.